N,N-Dimethylglycine → HCID 58529790, compound
Reaction equation
[CH2:1]([O:8][C:9]1[CH:10]=[C:11]([C:15]2[CH:16]=[C:17]([CH:25]3[CH2:30][CH2:29][NH:28][CH2:27][CH2:26]3)[N:18]3[C:23]=2[C:22]([NH2:24])=[N:21][CH:20]=[N:19]3)[CH:12]=[CH:13][CH:14]=1)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.[CH3:31][N:32]([CH3:37])[CH2:33][C:34](O)=[O:35]>>[CH2:1]([O:8][C:9]1[CH:10]=[C:11]([C:15]2[CH:16]=[C:17]([CH:25]3[CH2:30][CH2:29][N:28]([C:34](=[O:35])[CH2:33][N:32]([CH3:37])[CH3:31])[CH2:27][CH2:26]3)[N:18]3[C:23]=2[C:22]([NH2:24])=[N:21][CH:20]=[N:19]3)[CH:12]=[CH:13][CH:14]=1)[C:2]1[CH:3]=[CH:4][CH:5]=[CH:6][CH:7]=1Participants
3
Procedure
In a manner similar to the procedure described for the preparation of Example 342 and using 5-(3-benzyloxyphenyl)-7-piperidin-4-ylpyrrolo[2,1-f][1,2,4]triazin-4-amine and N,N-dimethylglycine as starting material, 20 mg (24%) of the desired product was isolated. 1H NMR (400 MHz, DMSO-d6) δ 7.90 (s, 1H), 7.45-7.30 (m, 6H), 7.10 (s, 1H), 7.05-6.97 (m, 2H), 6.56 (s, 1H), 5.13 (s, 2H), 4.48-4.42 (m, 1H), 4.18-4.12 (m, 1H), 3.41-3.32 (m, 3H), 3.20-3.10 (m, 2H), 3.05-2.97 (m, 1H), 2.76-2.68 (m, 1H), 2.16 (s, 6H), 2.06-1.98 (m, 2H); LC-MS m/z [M+H]+ 485.3, RT 2.32 min.
Workup
- customIn a manner similar to the procedure described for the preparation of Example 342
Sources & evidence
- ORD record
- ord-e8d09ebb4b914de78789b439f3456cd5
- Source dataset
- uspto-grants-2013_04
- Patent number
- US08431695B2
Reaction notes
Loading…